New combo therapy aims to tackle rare nasal cancer
NCT ID NCT05027633
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can shrink advanced squamous cell cancers of the nasal cavity and sinuses better than chemotherapy alone. About 35 adults with newly diagnosed, untreated stage II to IVb disease will receive the combination. The main goal is to see how many patients respond, while also checking safety and tolerability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pembrolizumab (immunotherapy) combined with docetaxel and cisplatin or carboplatin (chemotherapy)
- What this could lead to
- If successful, this combination could become a new standard treatment option for advanced nasal and sinus cancers, potentially improving tumor shrinkage and survival.
- What could go wrong
- This is a small, early-phase trial with only 35 participants, so results may not apply to everyone. Adding immunotherapy to chemotherapy can increase side effects like immune-related inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARANASAL SINUSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Glowing cancer cells: a new way to see tumors during surgery?
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Immunotherapy before surgery may cut skin cancer recurrence
- Mouth rinse could ease painful radiation side effects for head and neck cancer patients
- New skin patch could speed recovery after skin cancer removal